Suppr超能文献

新型抗癫痫药的研制。IV. 1-(对-氨磺酰基苯基)-吡咯烷-2-酮某些衍生物的抗惊厥活性(作者译)

[Development of new antiepileptics. IV. Anticonvulsant activity of some derivatives of 1-(p-sulfamoyl-phenyl)-pyrrolidin-2-one (author's transl)].

作者信息

Waser P G, Ganz A J, Pfirrmann R W

出版信息

Arzneimittelforschung. 1978;28(6):952-6. doi: 10.1002/chin.197841192.

Abstract

A series of derivatives of 1-(p-sulfamoyl-phenyl)-pyrrolidin-2-one were tested for anticonvulsant properties in rats and mice. The substance 1-(o-chloro-p-sulfamoyl-phenyl)-4-phenyl-pyrrolidin-2-one (1725) was found to have potent anticonvulsant activities in rats and mice against seizures induced by electroshock or pentylenetetrazol. The unsubstituted phenyl ring has to be in position 4, otherwise the activity of the product is weakened. The ortho position of the halogen atom on the N-phenyl is also important for the anticonvulsant effect; chlorine acts better than fluorine. The anticonvulsants tested also potentiate the sleeping time induced by pentobarbitone and attenuate the motor activity of mice. 1-(o-Chloro-p-sulfamoyl-phenyl)-4-phenyl-pyrrolidin-2-one (1725) has a LD50 of 1000 mg/kg p.o.; the lesser active substances generally have a LD50 greater than 5000 mg/kg p.o. Toxic effects of large doses were manifested by sedation and diarrhoea.

摘要

对一系列1-(对磺酰胺基苯基)-吡咯烷-2-酮衍生物进行了大鼠和小鼠抗惊厥特性测试。发现物质1-(邻氯-对磺酰胺基苯基)-4-苯基-吡咯烷-2-酮(1725)在大鼠和小鼠中对电休克或戊四氮诱导的惊厥具有强效抗惊厥活性。未取代的苯环必须位于4位,否则产物的活性会减弱。N-苯基上卤素原子的邻位对抗惊厥作用也很重要;氯的效果比氟好。所测试的抗惊厥药还能延长戊巴比妥诱导的睡眠时间,并减弱小鼠的运动活性。1-(邻氯-对磺酰胺基苯基)-4-苯基-吡咯烷-2-酮(1725)经口服的半数致死量为1000 mg/kg;活性较低的物质经口服的半数致死量通常大于5000 mg/kg。大剂量的毒性作用表现为镇静和腹泻。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验